PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes
about
Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives.The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban).Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis.Tailoring of medical treatment: hemostasis and thrombosis towards precision medicineEffects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary Intervention.Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population.
P2860
Q37724614-A89257C6-C23A-4F11-AC8A-5DD8A710445AQ38750444-2D87EAB6-E035-443D-B306-26DC8662E61CQ41631965-0309A339-9904-4EA6-85E4-8809B6DC1BC8Q42361969-10EFD59E-E40E-40B1-AFDC-68144D81E71CQ48123523-8B302221-1AA0-4D38-BFD2-DE3553B10B12Q55432293-BB1CFD9D-0755-47B3-B784-5D7AF7CE8662Q55471692-426779DE-E6B7-4E53-A422-2A125CCE6FF3
P2860
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2015
@uk
name
PON1 Q192R genetic variant and ...... -analysis of clinical outcomes
@en
PON1 Q192R genetic variant and ...... -analysis of clinical outcomes
@nl
type
label
PON1 Q192R genetic variant and ...... -analysis of clinical outcomes
@en
PON1 Q192R genetic variant and ...... -analysis of clinical outcomes
@nl
prefLabel
PON1 Q192R genetic variant and ...... -analysis of clinical outcomes
@en
PON1 Q192R genetic variant and ...... -analysis of clinical outcomes
@nl
P2093
P2860
P50
P1476
PON1 Q192R genetic variant and ...... -analysis of clinical outcomes
@en
P2093
Dietmar Trenk
Dirk Sibbing
Elliott M Antman
Jean-Philippe Collet
Jessica L Mega
Jessica T Delaney
Joseph R Walker
Marc S Sabatine
Matthew J Price
Michael Man
P2860
P2888
P304
P356
10.1007/S11239-015-1264-9
P577
2016-04-01T00:00:00Z